Luye Pharma Aims To Mimic Sihuan Pharma With Stock Exchange Switch
This article was originally published in PharmAsia News
Executive Summary
In dumping the Singapore stock exchange for Hong Kong's where it launched a $764 million initial public offering last week, China's Luye Pharma Group joined several previous switchers, including another drug maker.